CYPHERPUNK TECHNOLOGIES INC (CYPH) Stock Fundamental Analysis

NASDAQ:CYPH • US52187K2006

0.65 USD
-0.02 (-2.83%)
Last: Feb 20, 2026, 01:13 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

CYPH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. CYPH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CYPH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CYPH had negative earnings in the past year.
  • CYPH had a negative operating cash flow in the past year.
  • In the past 5 years CYPH always reported negative net income.
  • In the past 5 years CYPH always reported negative operating cash flow.
CYPH Yearly Net Income VS EBIT VS OCF VS FCFCYPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -445.76%, CYPH is not doing good in the industry: 93.86% of the companies in the same industry are doing better.
  • CYPH's Return On Equity of -1885.42% is on the low side compared to the rest of the industry. CYPH is outperformed by 81.19% of its industry peers.
Industry RankSector Rank
ROA -445.76%
ROE -1885.42%
ROIC N/A
ROA(3y)-109.13%
ROA(5y)-86.19%
ROE(3y)-140.51%
ROE(5y)-107.95%
ROIC(3y)N/A
ROIC(5y)N/A
CYPH Yearly ROA, ROE, ROICCYPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K

1.3 Margins

  • CYPH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYPH Yearly Profit, Operating, Gross MarginsCYPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, CYPH has more shares outstanding
  • CYPH has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CYPH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CYPH Yearly Shares OutstandingCYPH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CYPH Yearly Total Debt VS Total AssetsCYPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • CYPH has an Altman-Z score of -72.72. This is a bad value and indicates that CYPH is not financially healthy and even has some risk of bankruptcy.
  • CYPH has a worse Altman-Z score (-72.72) than 92.51% of its industry peers.
  • CYPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -72.72
ROIC/WACCN/A
WACCN/A
CYPH Yearly LT Debt VS Equity VS FCFCYPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 1.21 indicates that CYPH should not have too much problems paying its short term obligations.
  • The Current ratio of CYPH (1.21) is worse than 83.69% of its industry peers.
  • A Quick Ratio of 1.21 indicates that CYPH should not have too much problems paying its short term obligations.
  • CYPH has a worse Quick ratio (1.21) than 82.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.21
CYPH Yearly Current Assets VS Current LiabilitesCYPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 36.79% over the past year.
EPS 1Y (TTM)36.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 13.35% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y38.47%
EPS Next 2Y30.62%
EPS Next 3Y19.23%
EPS Next 5Y13.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYPH Yearly Revenue VS EstimatesCYPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 500K 1M 1.5M
CYPH Yearly EPS VS EstimatesCYPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • CYPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CYPH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYPH Price Earnings VS Forward Price EarningsCYPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYPH Per share dataCYPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CYPH's earnings are expected to grow with 19.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.62%
EPS Next 3Y19.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CYPH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CYPHERPUNK TECHNOLOGIES INC

NASDAQ:CYPH (2/20/2026, 1:13:38 PM)

0.65

-0.02 (-2.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-24
Inst Owners14.48%
Inst Owner ChangeN/A
Ins Owners10.99%
Ins Owner Change27.17%
Market Cap36.82M
Revenue(TTM)N/A
Net Income(TTM)-50.81M
Analysts43.33
Price TargetN/A
Short Float %23.02%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.05%
Min EPS beat(2)-35.23%
Max EPS beat(2)67.32%
EPS beat(4)2
Avg EPS beat(4)8.97%
Min EPS beat(4)-35.23%
Max EPS beat(4)67.32%
EPS beat(8)5
Avg EPS beat(8)7.5%
EPS beat(12)8
Avg EPS beat(12)-11.28%
EPS beat(16)10
Avg EPS beat(16)-10.76%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 13.66
P/tB 13.66
EV/EBITDA N/A
EPS(TTM)-1.22
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.93
FCFYN/A
OCF(TTM)-0.93
OCFYN/A
SpS0
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -445.76%
ROE -1885.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-109.13%
ROA(5y)-86.19%
ROE(3y)-140.51%
ROE(5y)-107.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.21
Altman-Z -72.72
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.82%
EPS Next Y38.47%
EPS Next 2Y30.62%
EPS Next 3Y19.23%
EPS Next 5Y13.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.81%
OCF growth 3YN/A
OCF growth 5YN/A

CYPHERPUNK TECHNOLOGIES INC / CYPH FAQ

What is the fundamental rating for CYPH stock?

ChartMill assigns a fundamental rating of 2 / 10 to CYPH.


Can you provide the valuation status for CYPHERPUNK TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 0 / 10 to CYPHERPUNK TECHNOLOGIES INC (CYPH). This can be considered as Overvalued.


How profitable is CYPHERPUNK TECHNOLOGIES INC (CYPH) stock?

CYPHERPUNK TECHNOLOGIES INC (CYPH) has a profitability rating of 0 / 10.


What is the financial health of CYPHERPUNK TECHNOLOGIES INC (CYPH) stock?

The financial health rating of CYPHERPUNK TECHNOLOGIES INC (CYPH) is 5 / 10.